Trial intelligence / Profile preview

ANAJIS

NCT00339157Phase 3Completed

Sponsor
Inserm
Start
May 2006
Primary completion
Jun 2008
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 3 trial of anakinra in Systemic Juvenile Idiopathic Arthritis (SJIA), sponsored by Inserm. Started May 2006; status: completed.

02

Drugs

anakinra
03

Conditions

Systemic Juvenile Idiopathic Arthritis (SJIA)

Beyond the preview

Go deeper on NCT00339157.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00339157.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call